loading

Cadrenal Therapeutics Inc Stock (CVKD) Forecast

The Cadrenal Therapeutics Inc (CVKD) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.066, representing a -99.53% decrease from the current price of $14.00. The highest analyst price target is $0.1236, and the lowest is $0.00843.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CVKD Price Target
Average 0.8522 (-93.91% Downside)
loading

Is Cadrenal Therapeutics Inc (CVKD) A Buy Now?

Oscillators
Name Value Action
RSI(14) 44.96 Neutral
STOCH(9,6) 20.36 Neutral
STOCHRSI(14) 27.41 Neutral
MACD(12,26) 0.2802 Sell
ADX(14) 25.36 Buy
William %R -94.72 Buy
CCI(14) -113.16 Sell
Buy: 2 Sell: 2 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
16.24
Sell
15.60
Sell
MA20
16.04
Sell
15.62
Sell
MA50
14.31
Buy
14.08
Buy
MA100
10.69
Buy
12.11
Buy
MA200
9.4196
Buy
10.88
Buy
Buy: 6 Sell: 4 Neutral: 0
Summary: Buy
According to our latest analysis, CVKD could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 6 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on CVKD, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 44.96 indicates that CVKD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 20.36 indicates that CVKD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 27.41 indicates that CVKD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 25.36 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -113.16 indicates that CVKD is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term CVKD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Cadrenal Therapeutics Inc financial reports and earnings history, Cadrenal Therapeutics Inc (CVKD) stock could reach $2.9011 by 2030, $11.10 by 2040 and $9.5657 by 2050. See the projected annual prices until 2050 of the Cadrenal Therapeutics Inc stock below:

  • Cadrenal Therapeutics Inc (CVKD) is expected to reach an average price of $5.8603 in 2035, with a high prediction of $6.2027 and a low estimate of $5.9384. This indicates an $-58.14% rise from the last recorded price of $14.00.
  • Cadrenal Therapeutics Inc (CVKD) stock is projected to chart a bullish course in 2040, with an average price target of $10.81, representing an $-22.77% surge from its current level. The forecast ranges from a conservative $10.81 to a sky-high $11.10.
  • Our analysts predict Cadrenal Therapeutics Inc (CVKD) to jump -61.09% by 2045, soaring from $5.4568 to an average price of $5.4468, potentially reaching $5.8265. While $5.4568 is the low estimate, the potential upside is significant.
  • Cadrenal Therapeutics Inc (CVKD) stock is expected to climb by 2050, reaching an average of $8.2339, a $-41.19% jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.5657 and $8.7239, respectively, highlighting the market's uncertainty.

Cadrenal Therapeutics Inc Stock (CVKD) Year by Year Forecast

Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2024

Our forecast for CVKD stock price in 2024 now indicates an average price target of $1.1745 with a high forecast of $2.3406 and a low forecast of $0.00843. The average prediction reflects an decrease of -91.61% from the last recorded price of $14.00.
Month Average Low High Change from today's price
December, 2024 $0.0325 $0.00843 $0.1236 -99.77%

Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2025

Cadrenal Therapeutics Inc Stock (CVKD) is expected to reach an average price of $0.8522 in 2025, with a high prediction of $1.7034 and a low estimate of $0.00102. This indicates an -93.91% fall from the last recorded price of $14.00.
Month Average Low High Change from today's price
January, 2025 $0.1815 $0.1228 $0.1531 -98.70%
February, 2025 $0.0645 $0.0931 $0.0645 -99.54%
March, 2025 $0.2146 $0.0183 $0.2517 -98.47%
April, 2025 $1.3436 $0.0444 $1.3736 -90.40%
May, 2025 $0.1927 $0.1641 $1.7034 -98.62%
June, 2025 $0.1899 $0.1219 $0.3325 -98.64%
July, 2025 $0.0524 $0.00102 $0.2715 -99.63%
August, 2025 $0.521 $0.0566 $0.221 -96.28%
September, 2025 $0.5127 $0.5127 $0.4803 -96.34%
October, 2025 $0.3548 $0.4049 $0.3672 -97.47%
November, 2025 $0.1561 $0.3066 $0.2507 -98.89%
December, 2025 $0.3088 $0.1374 $1.5413 -97.79%

Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2026

The predicted value for Cadrenal Therapeutics Inc (CVKD) in 2026 is set at an average of $0.7368. Estimates vary from a peak of $1.446 to a trough of $0.0276, indicating an -94.74% surge from the present price of $14.00.
Month Average Low High Change from today's price
January, 2026 $0.6305 $0.4191 $0.66 -95.50%
February, 2026 $0.6721 $0.7517 $0.6792 -95.20%
March, 2026 $0.6588 $0.603 $0.5583 -95.29%
April, 2026 $0.7984 $0.6806 $0.696 -94.30%
May, 2026 $0.7215 $0.7873 $0.7763 -94.85%
June, 2026 $0.5907 $0.6576 $0.629 -95.78%
July, 2026 $0.2625 $0.4115 $0.5298 -98.12%
August, 2026 $0.4168 $0.0276 $1.2368 -97.02%
September, 2026 $0.143 $0.1554 $0.5262 -98.98%
October, 2026 $0.1471 $0.1571 $0.1267 -98.95%
November, 2026 $0.2483 $0.2176 $0.2684 -98.23%
December, 2026 $1.4578 $0.2086 $1.446 -89.59%

Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Cadrenal Therapeutics Inc (CVKD) is $0.7454, with a high forecast of $1.43 and a low forecast of $0.0608. This indicates an -94.68% decrease from the last price of $14.00.
Month Average Low High Change from today's price
January, 2027 $1.4104 $1.3997 $1.3384 -89.93%
February, 2027 $1.2429 $1.2923 $1.2742 -91.12%
March, 2027 $0.8861 $0.9661 $1.1186 -93.67%
April, 2027 $1.1709 $1.0374 $0.9387 -91.64%
May, 2027 $1.4943 $1.47 $1.43 -89.33%
June, 2027 $1.1745 $1.3045 $1.4198 -91.61%
July, 2027 $1.3545 $1.3527 $1.2745 -90.32%
August, 2027 $1.4286 $1.3576 $1.3995 -89.80%
September, 2027 $1.2628 $1.2727 $1.3602 -90.98%
October, 2027 $1.0694 $1.1473 $1.1935 -92.36%
November, 2027 $0.4579 $0.7607 $0.8013 -96.73%
December, 2027 $0.5412 $0.0608 $0.7701 -96.13%

Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2028

In 2028, Cadrenal Therapeutics Inc (CVKD) is projected to reach an average price of $1.4701, with a high projection of $2.4118 and a low estimate of $0.5284. This indicates an -89.50% fall from the last price of $14.00.
Month Average Low High Change from today's price
January, 2028 $0.5541 $0.5731 $0.5237 -96.04%
February, 2028 $0.5473 $0.5356 $0.515 -96.09%
March, 2028 $0.573 $0.5284 $0.6176 -95.91%
April, 2028 $2.3446 $2.4819 $2.4118 -83.25%
May, 2028 $2.1888 $2.2785 $2.2254 -84.37%
June, 2028 $2.0623 $2.1022 $2.017 -85.27%
July, 2028 $1.7657 $1.7948 $1.7832 -87.39%
August, 2028 $2.23 $1.8465 $2.20 -84.07%
September, 2028 $2.2123 $2.2134 $2.1604 -84.20%
October, 2028 $1.9668 $2.006 $2.0952 -85.95%
November, 2028 $2.0451 $2.0101 $1.9466 -85.39%
December, 2028 $1.9924 $2.0195 $2.0227 -85.77%

Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2029

The 2029 price forecast for Cadrenal Therapeutics Inc Stock (CVKD) is $1.8966 on average, with a high prediction of $3.3775 and a low estimate of $0.4156. This represents an -86.45% decrease from the previous price of $14.00.
Month Average Low High Change from today's price
January, 2029 $1.7001 $1.7788 $1.8156 -87.86%
February, 2029 $1.4699 $1.5022 $1.6196 -89.50%
March, 2029 $0.0856 $0.4156 $1.2454 -99.39%
April, 2029 $1.1191 $0.8459 $0.9491 -92.01%
May, 2029 $0.9033 $0.9908 $0.9499 -93.55%
June, 2029 $0.9952 $0.9142 $0.9668 -92.89%
July, 2029 $3.4475 $0.8482 $3.1475 -75.38%
August, 2029 $2.9728 $3.2528 $3.3775 -78.77%
September, 2029 $3.017 $3.0671 $3.0882 -78.45%
October, 2029 $2.6525 $2.6825 $2.8543 -81.05%
November, 2029 $2.7069 $2.6235 $2.4857 -80.67%
December, 2029 $2.9111 $2.7878 $2.97 -79.21%

Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2030

Cadrenal Therapeutics Inc Stock (CVKD) is expected to reach an average price of $2.6176 in 2030, with a high forecast of $4.3432 and a low forecast of $0.892. This signifies an -81.30% decrease from the last price of $14.00.
Month Average Low High Change from today's price
January, 2030 $2.6654 $2.8114 $2.9011 -80.96%
February, 2030 $2.6806 $2.697 $2.6188 -80.85%
March, 2030 $2.6973 $2.6627 $2.5949 -80.73%
April, 2030 $2.503 $2.5688 $2.6459 -82.12%
May, 2030 $2.2146 $2.2742 $2.3224 -84.18%
June, 2030 $1.7798 $1.9288 $2.0276 -87.29%
July, 2030 $1.2642 $0.892 $1.3999 -90.97%
August, 2030 $1.3961 $1.4085 $1.3863 -90.03%
September, 2030 $1.2827 $1.2927 $1.3395 -90.84%
October, 2030 $1.2081 $1.2281 $1.3159 -91.37%
November, 2030 $4.3256 $1.1681 $4.3432 -69.10%
December, 2030 $4.1607 $4.1794 $4.1769 -70.28%
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):